Retatrutide 40mg

Retatrutide is an innovative triple agonist peptide that targets GLP-1, GIP, and glucagon receptors simultaneously, setting a new benchmark in the field of metabolic research. By activating these three key pathways, Retatrutide has demonstrated exceptional potential in promoting weight loss, improving insulin sensitivity, and supporting overall metabolic health.

Sold For laboratory research use only. Not for human or animal consumption. Not a drug, food, or cosmetic.

Data is provided for informational purposes only and is derived from published scientific literature.